Chanthavanich, Pornthep <br/><br/>
Safety, Tolerability and Immunogenicity of an MF59-adjuvanted, Cell Culture-derived, A/H5N1, Subunit Influenza Virus Vaccine: Results From a Dose-finding Clinical Trial in Healthy Pediatric Subjects.  [electronic resource] 

 -  The Pediatric infectious disease journal  07 2019 
 - 757-764 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1532-0987 
<br/><br/><label>Standard No.: </label>10.1097/INF.0000000000002345  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adolescent<br/>Antibodies, Viral--blood<br/>Child<br/>Child, Preschool<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Female<br/>Healthy Volunteers<br/>Hemagglutination Inhibition Tests<br/>Humans<br/>Infant<br/>Influenza A Virus, H5N1 Subtype--immunology<br/>Influenza Vaccines--administration & dosage<br/>Influenza, Human--prevention & control<br/>Male<br/>Polysorbates--administration & dosage<br/>Single-Blind Method<br/>Squalene--administration & dosage<br/>United States<br/>Vaccines, Subunit--administration & dosage